Quinolones in gastrointestinal infections.
Fluoroquinolones are efficient antimicrobial drugs for the treatment of enteric fever, shigellosis, Escherichia coli diarrhea, cholera, and traveler's diarrhea. They also play a role in the therapy of yersiniosis, campylobacteriosis, and intestinal salmonellosis. A single dose of quinolones has been effective in the treatment of traveler's diarrhea and cholera. Uncomplicated typhoid fever was cured by norfloxacin, pefloxacin, and ofloxacin 400 mg twice daily (b.i.d.) for 7-14 days or ciprofloxacin 500 mg b.i.d. for 10 days. A single daily dose of 400 mg fleroxacin for 3 days has been shown to be effective in this indication. A few reports suggest that the newer quinolones can eliminate the carrier state. The efficacy of quinolones in the prophylaxis and treatment of intra-abdominal infections following abdominal surgery requires further investigation.
Graninger
W
W
Department of Infectious Diseases and Chemotherapy, University of Vienna, Austria.
Zedtwitz-Liebenstein
K
K
Laferl
H
H
Burgmann
H
H
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D001424:Bacterial Infections / Q000188:drug therapy*; D002771:Cholera / Q000188:drug therapy; D003967:Diarrhea / Q000188:drug therapy / Q000517:prevention & control; D024841:Fluoroquinolones; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D016481:Helicobacter Infections / Q000188:drug therapy; D006801:Humans; D008199:Lymphadenitis / Q000188:drug therapy; D010538:Peritonitis / Q000188:drug therapy; D014435:Typhoid Fever / Q000188:drug therapy
D000890:Anti-Infective Agents; D024841:Fluoroquinolones